The response of neuregulin 1 mutant mice to acute restraint stress

Neuroscience Letters

Volumn 515, Issue 1, 2012, Pages 82-86

  Chesworth, Rose ^a,b,c   Yulyaningsih, Ernie ^a,d   Cappas, Emily ^a,b   Arnold, Jonathon ^b,f   Sainsbury, Amanda ^a,d,e   Karl, Tim ^a,b,c,d  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f University of Sydney   (Australia)

Author keywords

Animal model; Corticosterone; Locomotion; Neuregulin 1; Restraint stress; Schizophrenia

Indexed keywords

CORTICOSTERONE; NEU DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GENOTYPE; IMMOBILIZATION STRESS; LOCOMOTION; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; STRESS; WILD TYPE;

ACUTE DISEASE; AGING; ANIMALS; CORTICOSTERONE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEUREGULIN-1; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 84859438890     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.024     Document Type: Article

References (35)

1. Asan E., Yilmazer-Hanke D.M., Eliava M., Hantsch M., Lesch K.P., Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 2005, 131:953-967.
2. Birkett M.A., Shinday N.M., Kessler E.J., Meyer J.S., Ritchie S., Rowlett J.K. Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacol. Biochem. Behav. 2011, 98:544-551.
3. Boucher A.A., Arnold J.C., Duffy L., Schofield P.R., Micheau J., Karl T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) 2007, 192:325-336.
4. Boucher A.A., Hunt G.E., Karl T., Micheau J., McGregor I.S., Arnold J.C. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience 2007, 149:861-870.
5. Y.-J. Chen, Type III Neuregulin 1 Functions In The Central Nervous System. Graduate School of Arts and Science, Vol. PhD, Columbia University, Columbia, 2007, p. 245.
6. Chesworth R., Downey L., Logge W., Killcross S., Karl T. Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav. Brain Res. 2012, 226:218-223.
7. Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., Malaspina D. The stress cascade and schizophrenia: etiology and onset. Schizophr. Bull. 2003, 29:671-692.
8. Denenberg V.H. Open-field behavior in the rat: what does it mean?. Ann. N. Y. Acad. Sci. 1969, 159:852-859.
9. Duffy L., Cappas E., Lai D., Boucher A.A., Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 2010, 170:800-807.
10. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003, 284:14-30.
11. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60:132-140.
12. Horan W.P., Ventura J., Nuechterlein K.H., Subotnik K.L., Hwang S.S., Mintz J. Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophr. Res. 2005, 75:363-374.
13. Hultman C.M., Wieselgren I.M., Ohman A. Relationships between social support, social coping and life events in the relapse of schizophrenic patients. Scandinavian J. Psychol. 1997, 38:3-13.
14. Karl T., Burne T.H., Van den Buuse M., Chesworth R. Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?. Behav. Brain Res. 2011, 223:336-341.
15. Karl T., Duffy L., Scimone A., Harvey R.P., Schofield P.R. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav. 2007, 6:677-687.
16. Karl T., Hoffmann T., Pabst R., von Horsten S. Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity. Pharmacol. Biochem. Behav. 2003, 75:869-879.
17. Karl T., Pabst R., von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp. Toxicol. Pathol. 2003, 55:69-83.
18. Keri S., Kiss I., Seres I., Kelemen O. A polymorphism of the neuregulin 1 gene (SNP8NRG243177/rs6994992) affects reactivity to expressed emotion in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:418-420.
19. Laarakker M., van Lith H., Ohl F. Behavioral characterization of A/J and C57BL/6J mice using a multidimensional test: association between blood plasma and brain magnesium-ion concentration with anxiety. Physiol. Behav. 2011, 102:205-219.
20. Long L.E., Chesworth R., Arnold J.C., Karl T. A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology (Berl) 2010, 211:277-289.
21. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
22. Mozhui K., Karlsson R.M., Kash T.L., Ihne J., Norcross M., Patel S., Farrell M.R., Hill E.E., Graybeal C., Martin K.P., Camp M., Fitzgerald P.J., Ciobanu D.C., Sprengel R., Mishina M., Wellman C.L., Winder D.G., Williams R.W., Holmes A. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J. Neurosci. 2010, 30:5357-5367.
23. Munafo M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 2006, 11:539-546.
24. Myin-Germeys I., van Os J., Schwartz J.E., Stone A.A., Delespaul P.A. Emotional reactivity to daily life stress in psychosis. Arch. Gen. Psychiatry 2001, 58:1137-1144.
25. Sainsbury A., Bergen H., Boey D., Bamming D., Cooney G., Lin S., Couzens M., Stroth N., Lee N., Lindner D., Singewald N., Karl T., Duffy L., Enriquez R., Slack K., Sperk G., Herzog H. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 2006, 55:19-26.
26. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 2008, 165:497-506.
27. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
28. Taylor S.B., Markham J.A., Taylor A.R., Kanaskie B.Z., Koenig J.I. Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats. Behav. Brain Res. 2011, 224:223-232.
29. Taylor S.B., Taylor A.R., Markham J.A., Geurts A.M., Kanaskie B.Z., Koenig J.I. Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli. Physiol. Behav. 2011, 104:205-214.
30. Tosato S., Dazzan P., Collier D. Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophr. Bull. 2005, 31:613-617.
31. Trainor B.C., Pride M.C., Villalon Landeros R., Knoblauch N.W., Takahashi E.Y., Silva A.L., Crean K.K. Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). PLoS One 2011, 6:e17405.
32. van den Buuse M., Wischhof L., Lee R.X., Martin S., Karl T. Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int. J. Neuropsychopharmacol. 2009, 12:1383-1393.
33. van Venrooij J.A., Fluitman S.B., Lijmer J.G., Kavelaars A., Heijnen C.J., Westenberg H.G., Kahn R.S., Gispen-de Wied C.C., Impaired Neuroendocrine Immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr. Bull. 2010.
34. van Winkel R., Stefanis N.C., Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 2008, 34:1095-1105.
35. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., Leach R.J., Almasy L., Escamilla M., Raventos H. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol. Psychiatry 2006, 60:548-553.